Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice

Cancer Research

Volumn 58, Issue 18, 1998, Pages 4127-4131

  Scotlandi, Katia ^a   Benini, Stefania ^a   Nanni, Patrizia ^b   Lollini, Pier Luigi ^b   Nicoletti, Giordano ^c   Landuzzi, Lorena ^c   Serra, Massimo ^a   Manara, Maria Cristina ^a   Picci, Piero ^a   Baldini, Nicola ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Unita Satellite di Biotecnologie   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; SOMATOMEDIN C RECEPTOR; SURAMIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE METASTASIS; CANCER REGRESSION; CELL GROWTH; CONTROLLED STUDY; DRUG CYTOTOXICITY; EWING SARCOMA; GROWTH INHIBITION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; FEMALE; MICE; MICE, NUDE; RECEPTORS, SOMATOMEDIN; SARCOMA, EWING'S; SURAMIN; TRANSPLANTATION, HETEROLOGOUS;

EID: 17744417798     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Campanacci, M. Bone and Soft Tissue Tumors. Vienna: Springer-Verlag, 1990.
2. Horowiiz, M. E., Kinsella, T. J., Wexler, L. H., Belasco, J., Triche, T., Tsokos, M., Steinberg, S. M., McClure, L., Longo, D. L., Steis, R. G., Glatstein, E., Pizzo, P. A., and Miser, J. S. Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J. Clin. Oncol., 11: 1911-1918, 1993.
3. Baserga, R. Oncogenes and the strategy of growth factors. Cell, 79: 927-930, 1994.
4. LeRoith, D., Baserga, R., Helman, L., and Roberts, C. T., Jr. Insulin-like growth factors and cancer. Ann. Intern. Med., 122: 54-59, 1995.
5. Kaleko, M., Rutter, W. J., and Miller, A. D. Overexpression of the human insulin-like growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol. Cell. Biol., 10: 464-473, 1990.
6. Sell, C., Rubini, M., Rubin, R., Liu, J-P., Efstratiadis, A., and Baserga, R. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type-1 IGF receptor. Proc. Natl. Acad. Sci. USA, 90: 11217-11221, 1993.
7. Sell, C., Dumenil, G., Deveaud, C., Miura, M., Coppola, D., De Angelis, T., Rubin, R., Efstratiadis, A., and Baserga, R. Effect of a null mutation of the type 1 IGF receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol., 14: 3604-3612, 1994.
8. Rogler, C. E., Yang, D., Rossetti, L., Donohoe, J., Alt, E., Chang, C. J., Rosenfeld, R., Neely, K., and Hintz, R. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J. Biol. Chem., 269: 13779-13784, 1994.
9. Bol. D. K., Kiguchi, K., Gimenez-Conti, I., Rupp, T., and Di Giovanni, J. Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice. Oncogene, 14: 1725-1734, 1997.
10. Baserga, R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res., 55: 249-252, 1995.
11. Yee, D., Favoni, R. E., Lebovic, G. S., Lombana, F., Powell, D. R., Reynolds, C. P., and Rosen, N. Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. J. Clin. Invest., 86: 1806-1814, 1990.
12. van Valen, F., Winkelmann, W., and Jürgens, H. Type I and type II insulin-like growth factor receptors and their function in human Ewing's sarcoma cells. J. Cancer Res. Clin. Oncol., 118: 269-275, 1992.
13. Scotlandi, K., Benini, S., Sani, M., Serra, M., Lollini, P-L., Maurici, D., Picci, P., Manara, M. C., and Baldini, N. Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target. Cancer Res., 56: 4570-4574, 1996.
14. Rohlik, Q. T., Adams, K., Kull, F. C., and Jacobs, S. An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochem. Biophys. Res. Commun., 149: 276-281, 1987.
15. Stein, C. A. Suramin: a novel antineoplastic agent with multiple potential mechanisms of action. Cancer Res., 53: 2239-2248, 1993.
16. Majno, G., and Joris, I. Apoptosis, oncosis, and necrosis: an overview of cell death. Am. J. Pathol., 146: 3-15, 1995.
17. Arteaga, C. L., and Osborne, C. K. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Cancer Res., 49: 6237-6241, 1989.
18. Furlanetto, R. W., Harwell, S. E., and Baggs, R. E. Effects of insulin-like growth factor receptor inhibitor on human melanomas in culture and in athymic mice. Cancer Res., 53: 2522-2526, 1993.
19. cdc2. Cancer Res, 54: 5531-5534, 1994.
20. LaRocca, R., Stein, C., Danesi, R., Jamis-Dow, C., Weiss, G., and Meyers, C. Suramin in adrenal cancer: modulation of steroid hormone production, cytotoxicity in vitro, and clinical antitumor effect. J. Clin. Endocrinol. Metab., 71: 497-503, 1990.
21. Eisenberg, M. A, Sinibaldi, V. J., Reyno, L. M., Sridhara, R., Jodrell, D. I., Zuhowski, E. G., Tkaezuke K. H., Lowitt, M. H., Hemady, R. K., Jacobs, S. C., VanEcho, D., and Egorin, M. J. Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer. J. Clin. Oncol. 13: 2174-2186, 1995.
22. Dawson, N. A., Figg, W. D., Cooper, M. R., Sartor, O., Bergan, R. C., Senderowicz, A. M., Steinberg, S. M., Tompkins, A., Weinberger, B., Sausville, E. A., Reed, E., and Myers, C. E. Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer. J. Clin. Oncol., 15: 1470-1477, 1997.
23. Pollak, M., and Richard, M. Suramin blockade of insulin-like growth factor I-stimulated proliferation of human osteosarcoma cells. J. Natl. Cancer Inst., 82: 1349-1352, 1990.
24. Walz, T. M., Abdiu, A., Wingren, S., Smeds, S., Larsson, S-E., and Wasteson, Å. Suramin inhibits growth of human osteosarcoma xenografts in nude mice. Cancer Res., 51: 3585-3589, 1991.
25. Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H. L., Kajstura, J., Rubin, R., Zoltik, P, and Baserga, R. The insulin-like growth factor 1 receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55: 2463-2469, 1995.
26. Zabrenetzky, V. S., Kohn, E. C., and Roberts, D. D. Suramin inhibits laminin- and thrombospondin-mediated melanoma cell adhesion and migration of these adhesive proteins to sulfatide. Cancer Res., 50: 5937-5942, 1990.